Application Notes & Case Studies

  1. What Successful eClinical Vendor Selection Looks Like

    Clinical research company implements EDC to gain efficiencies in mobile data capture and perform real-time data analysis to quickly validate data quality.

  2. eCOA Solution in Pediatric Clinical Trial Reduces Burden on Caregivers

    In this example of eCOA in a rare disease clinical trial, handheld devices reduce the burden of data collection for caregivers of children.

  3. CRO Rescues Multi Study Program Utilizing EDC Solution

    How the right team and tools can make all the difference in clinical trial rescue scenarios.

  4. How eClinical Flexibility Leads To Study Success

    With each clinical research initiative bringing its own set of requirements and challenges to the table, leveraging a technology solution that’s flexible enough to work the way you need it to is beneficial.

  5. Successfully Managing Disease-Specific Registries With eClinical Technology

    Healthcare technology company’s solution supports industry-academia collaborative registry and facilitates quick attainment of enrollment goals and generation of multiple publications.

  6. An Innovative Solution To Flexibly Meet Unique Primary Packaging Requirements

    A customer enlisted Catalent to support their child-resistant blister packaging requirements for a global Phase III study. A flexible design was created with an integrated blister card that could also support larger study requirements of 1.9 million monthly dosing cards. Through customized commercial blistering equipment a solution was provided that would accommodate the customer’s growing demands for clinical supplies.

  7. eCOA Provider Collaborates With Hospital To Create Electronic Version Of The Neurostatus-EDSS

    Examine how the electronic Neurostatus-EDSS replaces the way data is captured in the traditional assessment that requires EDSS raters to complete paper forms that suffer from all the typical issues with inter- and intra-rater reliability.

  8. Unlock Oral Delivery Potential For Macromolecules With A Parallel Screening Approach

    Identifying the optimal formulation and dose form which shows an increase more than 20 times in the oral bioavailability of Salmon Calcitonin.

  9. Developing Oral Dosage Forms: An Approach For Faster Path To Market

    How an agnostic and data-driven approach early on can optimize the development pathway to bring the molecule to the market faster.

  10. Breakthrough-Designation Increases Stress On Clinical Supply Chain

    While Andexanet Alfa’s Breakthrough Designation added additional stress to the supply chain, Portola and Sherpa navigated these issues by devising fast, flexible and responsive approaches to supply chain management.